Table 1.
Group | n = 12,172 |
---|---|
Age [years, n (%)] | |
15–64 | 9,226 (75.8) |
65–74 | 1,668 (13.7) |
≥75 | 1,278 (10.5) |
Gender [n (%)]a | |
Female | 5,036 (46) |
Male | 5,922 (54) |
Race/ethnicity [n (%)] | |
Hispanic | 4,138 (34) |
Black | 1,826 (15) |
White | 5,356 (44) |
Other | 852 (7) |
Health insurance [n (%)] | |
Private | 3,980 (33) |
Medicare | 4,008 (33) |
Medicaid | 1,408 (12) |
Uninsured | 2,354 (19) |
Other | 417 (4) |
Missing | 5 (<1) |
Chronic comorbidities [n (%)]b | |
Any | 8,793 (72.2) |
Congestive heart failure | 1,557 (12.8) |
Peripheral vascular disease | 1,239 (10.2) |
Chronic pulmonary disease | 1,368 (11.2) |
Diabetes mellitus | 5,794 (47.6) |
Dementia | 90 (0.7) |
Myocardial infarction | 439 (3.6) |
Connective tissue disease | 287 (2.4) |
Cerebrovascular disease | 474 (3.9) |
Chronic renal failure | 1,882 (15.5) |
Malignancy | 578 (4.7) |
Chronic liver disease | 786 (6.5) |
HIVc infection | 74 (0.6) |
Deyo-Charlson score | |
mean (SD) | 1.8 (1.9) |
Obesity [n (%)] | 1,855 (15.2) |
Drug abuse [n (%)] | 586 (4.8) |
Alcohol abuse [n (%)] | 628 (5.2) |
aGender was masked in 1214 hospitalizations. The denominator used to derive female/male percentage for the cohort was based on hospitalizations with available gender designation (n = 10,958); bbased on the Deyo-Charlson comorbidity index; chuman immunodeficiency virus.